Home › Funds › Artisan Partners Limited Partnership › ASND

Artisan Partners Limited Partnership position in ASND

ASCENDIS PHARMA A/S · Health Care

Artisan Partners Limited Partnership reported holding 2,083,019 shares of ASND (ASCENDIS PHARMA A/S) in its Q3 2026 13F filing — a position valued at US$474.6M, representing 0.88% of its reported portfolio and ranking #30 among its reported holdings. Artisan Partners Limited Partnership has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)2.08M sh
Reported value held$474.58M
Portfolio Weight0.88%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How Artisan Partners Limited Partnership's ASND position evolved

Artisan Partners Limited Partnership first disclosed a stake in ASND in Q3 2023 at 5,995,408 shares (US$561.4M). The position peaked in Q1 2024 at 5,671,934 shares, worth US$857.4M. Across 13 filings, Artisan Partners Limited Partnership increased the stake 2 time(s), trimmed it 9 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 2,083,019 shares valued at US$474.6M — a reduction of -551,005 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 6.00M $561.41M New
Q4 2023 5.75M $724.12M Reduce
Q1 2024 5.67M $857.43M Reduce
Q2 2024 4.30M $585.76M Reduce
Q3 2024 4.41M $658.62M Add
Q4 2024 4.45M $612.69M Add
Q1 2025 4.26M $663.44M Reduce
Q2 2025 3.99M $688.75M Reduce
Q3 2025 3.72M $739.75M Reduce
Q4 2025 3.23M $687.89M Reduce
Q1 2026 3.23M $738.84M Hold
Q2 2026 2.63M $702.55M Reduce
Q3 2026 2.08M $474.58M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ASND and 13F data

ASND (ASCENDIS PHARMA A/S) is a Health Care company. 36 other funds we track also report a position in ASND — the largest reported positions include RA CAPITAL MANAGEMENT, L.P. (US$2.74B), T. Rowe Price Investment Management, Inc. (US$1.80B), Avoro Capital Advisors LLC (US$1.36B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ASND

All ASND fund holders →

FAQ

How long has Artisan Partners Limited Partnership held ASND?

Artisan Partners Limited Partnership has disclosed ASND holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is Artisan Partners Limited Partnership's current position in ASND?

As of Q3 2026, Artisan Partners Limited Partnership holds 2.08M shares of ASND (ASCENDIS PHARMA A/S), valued at $474.58M, representing 0.88% of its reported portfolio and ranking #30.

Has Artisan Partners Limited Partnership been buying or selling ASND?

In the latest 13F filing (Q3 2026), Artisan Partners Limited Partnership reduced its position in ASND. The position peaked in Q1 2024 at 5.67M shares.

Which other funds hold ASND?

Other major institutional holders of ASND include RA CAPITAL MANAGEMENT, L.P., T. Rowe Price Investment Management, Inc., Avoro Capital Advisors LLC, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.